TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions
Cannabis Law Report
OCTOBER 5, 2021
The review excludes pre-clinical trials (i.e. This is why we are delighted to invite you to our International Summit on Psychedelic Therapies for Mental Illness and 2-day Introductory Workshop Program in Psychedelic Therapies this November 17th – 20th. experimental pharmacology studies in test tube or animal models).
Let's personalize your content